LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $38,889,000 | +7.3% | 5,220,046 | +0.1% | 0.02% | +5.3% |
| Q4 2016 | $36,233,000 | +101.9% | 5,213,328 | +139.0% | 0.02% | +111.1% |
| Q3 2016 | $17,950,000 | -32.2% | 2,181,100 | -35.6% | 0.01% | -35.7% |
| Q2 2016 | $26,467,000 | +139.2% | 3,388,500 | +55.6% | 0.01% | +133.3% |
| Q1 2016 | $11,064,000 | -34.2% | 2,178,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $16,814,000 | +38.6% | 2,178,000 | +3.4% | 0.01% | +50.0% |
| Q3 2015 | $12,131,000 | -37.2% | 2,106,100 | 0.0% | 0.01% | -33.3% |
| Q2 2015 | $19,313,000 | +20.8% | 2,106,100 | +59.6% | 0.01% | +28.6% |
| Q1 2015 | $15,985,000 | – | 1,320,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,188,331 | $15,209,000 | 19.14% |
| ACUTA CAPITAL PARTNERS, LLC | 3,809,944 | $26,479,000 | 9.85% |
| Avoro Capital Advisors LLC | 4,520,643 | $31,418,000 | 6.35% |
| Broadfin Capital, LLC | 2,638,259 | $18,336,000 | 2.04% |
| Perceptive Advisors | 3,567,553 | $24,794,000 | 1.76% |
| Ghost Tree Capital, LLC | 975,000 | $6,776,000 | 1.63% |
| Opaleye Management Inc. | 300,000 | $2,085,000 | 1.23% |
| Rhenman & Partners Asset Management AB | 650,000 | $4,518,000 | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $1,043,000 | 0.39% |
| QVT Financial LP | 1,498,809 | $10,349,000 | 0.31% |